Stay updated on AK104 Bispecific Antibody Clinical Trial
Sign up to get notified when there's something new on the AK104 Bispecific Antibody Clinical Trial page.

Latest updates to the AK104 Bispecific Antibody Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe Record History shows a new revision v3.3.2 added and v3.3.1 removed, which is a minor administrative update and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe record history shows a revision update from v3.2.0 to v3.3.1 on the page. No study data, statuses, or core content were changed.SummaryDifference0.1%

- Check45 days agoChange DetectedThe notice about government funding and operating status at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedRecord history shows updates to recruitment status and study status across versions, reflecting changes in enrollment progress and the trial's current state. This helps users determine whether the study is actively recruiting.SummaryDifference0.1%

- Check88 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.SummaryDifference13%

Stay in the know with updates to AK104 Bispecific Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Bispecific Antibody Clinical Trial page.